CVS Health Co. (NYSE:CVS) Stock Position Boosted by Integrated Advisors Network LLC

Integrated Advisors Network LLC grew its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 162.1% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 62,545 shares of the pharmacy operator's stock after purchasing an additional 38,678 shares during the period. Integrated Advisors Network LLC's holdings in CVS Health were worth $4,237,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. Stonebridge Financial Group LLC bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $28,000. Hopwood Financial Services Inc. bought a new position in shares of CVS Health in the fourth quarter worth about $29,000. McIlrath & Eck LLC lifted its holdings in CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 174 shares in the last quarter. Financial Perspectives Inc raised its holdings in CVS Health by 137.5% during the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after acquiring an additional 466 shares during the period. Finally, MidAtlantic Capital Management Inc. raised its stake in CVS Health by 112.1% during the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock valued at $37,000 after purchasing an additional 437 shares during the period. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Trading Up 0.3%

Shares of CVS traded up $0.18 during trading hours on Thursday, hitting $65.90. The stock had a trading volume of 2,288,601 shares, compared to its average volume of 10,989,814. The firm has a market cap of $83.36 billion, a P/E ratio of 18.01, a P/E/G ratio of 0.98 and a beta of 0.56. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The company's fifty day simple moving average is $65.11 and its 200 day simple moving average is $60.05.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.31 earnings per share. Equities research analysts forecast that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 4.04%. CVS Health's payout ratio is 63.48%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their price objective on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research report on Tuesday, February 18th. Piper Sandler upped their price objective on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. Cowen reissued a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Mizuho lifted their price objective on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Two investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, CVS Health presently has an average rating of "Moderate Buy" and a consensus price target of $74.75.

Insider Transactions at CVS Health

In other news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the transaction, the director now owns 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 1.22% of the company's stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.